Location: Home
  • search
  • go
  • Relate News
  • 10/21/2024Changing Chinese Market Dynamics Hit Merck Where It Hurts (SCRIP Citel...
  • 10/18/2024AstraZeneca Submits Marketing Applications for Tremelimumab and Durval...
  • 10/18/2024AsiFlyer Secures CNY Tens of Mlns in Series Pre-A+ Financing to Advanc...
  • 10/18/2024LaNova Medicines Secures CNY 300M in Series C1 Financing to Advance On...
  • 10/18/2024NMPA Launches Pilot Reform for Staged Production of Biologicals
  • 10/18/2024CDE Solicits Comments on the Technical Guidelines for Clinical Risk Ma...
  • 10/18/2024CDE Publicizes the List of Reference Formulations for GQCE Studies (87...
  • 10/18/2024Recent Executive Moves
  • 10/17/2024Novartis, Chengdu Baiyu in Licensing Deal for Latter's Tumor Small Mol...
  • 10/17/2024MSD Files NDA for WINREVAIR (sotatercept) in China
  • 10/17/2024Portal Biotech Secures Multi-Million RMB Angel Financing
  • 10/17/2024Gan & Lee Achieves Primary Endpoints in Phase 2 Trials of Three Diabet...
  • 10/17/2024China Initiates Data Collection for the 10th Round of the National Lev...
  • 10/17/2024Hutchmed Announces Positive Results from Phase II SAVANNAH Trial for L...
  • 10/17/2024NMPA Holds National Drug Distribution Supervision Work Conference
  • 10/16/2024Eli Lilly Expands Innovation Centers to Beijing with New Research Faci...
  • 10/16/2024TenNor Announces CNY 300M+ Financing to Support Development and Comme...
  • 10/16/2024Cytokinetics and Jixing Pharma Jointly Submit Chinese NDA for Aficamte...
  • 10/16/2024Hengrui Resubmits BLA to the USFDA for Anti-PD-1 Antibody Camrelizumab
  • 10/16/2024GSK's Submits Priority Review Application for BCMA ADC in China
  • 10/16/2024Akeso Launches Phase 1/2 Trial of AK129 and AK117
  • 10/16/2024Hengrui Medicine Launches Phase 1/2 Trial for Nectin-4 ADC SHR-A2102 i...
  • 10/16/2024Hinova Pharma Receives IND Approval for PROTAC Candidate HP568 in Chin...
  • 10/16/2024Novartis to Negotiate NRDL Inclusion of siRNA Cholesterol-Reduction Dr...
  • 10/16/2024NHSA Issues the Notice on Regulating the Management of Externally-fill...
  • 10/16/2024China's New Policies On Foreign Investment In Healthcare And Biotechno...
  • 10/16/2024China Biopharma Tracker – Q3 2024 (PharmaDJ)
  • 10/16/2024Understanding the NewCo Model: A Trending Approach of Chinese Pharmace...
  • 10/16/2024As U.S. Efforts Stall, China Pushes Ahead with CRISPR Treatments for M...
  • 10/15/2024AstraZeneca/Daiichi's Enhertu Approved in China as First HER2-directed...
  • Page:32/761 Total number of articles:22830: [First][<<] [30] [31] [32] [33] [34] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group